IL6 and neoplasm: IHC analysis of the harvested tumours indicated the corresponding changes of IRAK1 and IL-6 expressions in IRAK1-depleted tumours and in ectopic IRAK1-rescued tumours compared with control tumours, although cell proliferation marker Ki67 remained unchanged (Fig. 5b).